BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 19249517)

  • 1. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma.
    Moonka D; Castillo E; Kumer S; Abouljoud M; Divine G; Pelletier S
    Transplant Proc; 2009; 41(1):216-8. PubMed ID: 19249517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.
    Porrett PM; Peterman H; Rosen M; Sonnad S; Soulen M; Markmann JF; Shaked A; Furth E; Reddy KR; Olthoff K
    Liver Transpl; 2006 Apr; 12(4):665-73. PubMed ID: 16482577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN; Perkins JD; Carithers RL
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
    Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
    Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the Model of End-Stage Liver Disease (MELD) organ allocation policy.
    Yao FY; Bass NM; Ascher NL; Roberts JP
    Liver Transpl; 2004 May; 10(5):621-30. PubMed ID: 15108253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit after liver transplantation: a single European center experience.
    Ravaioli M; Grazi GL; Dazzi A; Bertuzzo V; Ercolani G; Cescon M; Cucchetti A; Masetti M; Ramacciato G; Pinna AD
    Transplantation; 2009 Sep; 88(6):826-34. PubMed ID: 19920783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes.
    Castillo E; Pelletier S; Kumer S; Abouljoud M; Divine G; Moonka D
    Transplant Proc; 2009; 41(1):219-21. PubMed ID: 19249518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma.
    Cheng SJ; Freeman RB; Wong JB
    Liver Transpl; 2002 Apr; 8(4):323-8. PubMed ID: 11965574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras.
    Kanwal F; Dulai GS; Spiegel BM; Yee HF; Gralnek IM
    Aliment Pharmacol Ther; 2005 Jan; 21(2):169-77. PubMed ID: 15679767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
    Buenadicha AL; Martín LG; Martín EE; Pajares Ad; Pérez AM; Seral CC; Marugán RB
    Transplant Proc; 2005 Nov; 37(9):3881-3. PubMed ID: 16386571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival on waiting list for liver transplantation before and after introduction of the model for end-stage liver disease score.
    Tenório AL; Macedo FI; Miranda LE; Fernandes JL; da Silva CM; Neto OL; Lacerda CM
    Transplant Proc; 2010 Mar; 42(2):407-11. PubMed ID: 20304152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.
    Hayashi PH; Trotter JF; Forman L; Kugelmas M; Steinberg T; Russ P; Wachs M; Bak T; Kam I; Everson GT
    Liver Transpl; 2004 Jan; 10(1):42-8. PubMed ID: 14755776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver allocation for hepatocellular carcinoma: a European Center policy in the pre-MELD era.
    Ravaioli M; Grazi GL; Ercolani G; Cescon M; Del Gaudio M; Zanello M; Ballardini G; Varotti G; Vetrone G; Tuci F; Lauro A; Ramacciato G; Pinna AD
    Transplantation; 2006 Feb; 81(4):525-30. PubMed ID: 16495798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of liver transplantation outcome in patients with MELD Score > or = 30.
    Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Meira-Filho SP; Rezende MB; Paes AT; Afonso RC
    Transplant Proc; 2008 Apr; 40(3):797-9. PubMed ID: 18455020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
    Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
    Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.